Biren Amin

Brian Skorney

Gil Blum

Joseph Schwartz

Ritu Baral

Tazeen Ahmad

Anupam Rama

David Hoang

Eliana Merle

Gavin Clark-Gartner

Huidong Wang

Konstantinos Biliouris

Kristen Kluska

Michael Ulz

Brian Abrahams

Leo Watson

Lin Tsai

Salveen Richter

Samantha Corwin

Tommie Reerink

Uy Ear

Andreas Argyrides

Andrew Tsai

Danielle Brill

Daniel Smith

Debjit Chattopadhyay

Gena Wang

Kevin

Kevin DeGeeter

Kostas Biliouris

Louise Chen

Mitchell Kapoor

Priyanka Grover

Robert Finke

Rohan

Ry Forseth

Sami Corwin

Tim Lugo

Yanan Zhu

- Sarepta Therapeutics, Inc. entered into agreements on **August 20, 2025**, to exchange **$700.0 million** in aggregate principal amount of its **1.25% Convertible Senior Notes due 2027**.  **[873303_0001193125-25-192794_d945054d8k.htm:1]** 
- The consideration for this exchange included **$602.0 million** in aggregate principal amount of new **4.875% Convertible Senior Notes due 2030**, **5,851,693 shares** of common stock, and approximately **$123.3 million** in cash.  **[873303_0001193125-25-192794_d945054d8k.htm:1]** 
- The new **4.875% Convertible Senior Notes due 2030** were issued on **August 28, 2025**, mature on **September 1, 2030**, and have an initial conversion price of approximately **$60.00 per share**, representing a **191.5% conversion premium** based on the August 20, 2025, common stock price of **$20.58**.  **[873303_0001193125-25-192794_d945054d8k.htm:1]** 
- Concurrently, the company completed a private placement of **1,106,806 shares** of common stock at a purchase price of **$18.07 per share**.  **[873303_0001193125-25-192794_d945054d8k.htm:4]**

Sarepta Therapeutics Completes Convertible Note Exchange and Private Placement

Sarepta Therapeutics (SRPT)